Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
Open Access
- 11 March 2025
- journal article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 54 (11) , 4685-4696
Abstract
High-Grade Serous Ovarian Cancer (HGSOC) is the most common and lethal subtype of ovarian cancer, known for its high aggressiveness and extensive genomic alterations.Keywords
All Related Versions
Funding Information
- Bijzonder Onderzoeksfonds UGent
- Fonds Wetenschappelijk Onderzoek
- Associazione Italiana per la Ricerca sul Cancro (IG23566)
- Ministero della Salute
This publication has 108 references indexed in Scilit:
- Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery SystemsAngewandte Chemie International Edition, 2023
- Indenyl and Allyl Palladate Complexes Bearing N‐Heterocyclic Carbene Ligands: an Easily Accessible Class of New Anticancer Drug CandidatesEuropean Journal of Inorganic Chemistry, 2022
- Allyl palladium complexes bearing carbohydrate‐based N‐heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicityApplied Organometallic Chemistry, 2020
- Palladium(II)‐η3‐Allyl Complexes Bearing N‐Trifluoromethyl N‐Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High‐Grade Serous Ovarian Cancer TumoroidsChemistry – A European Journal, 2020
- Towards Light‐Activated Ruthenium–Arene (RAPTA‐Type) Prodrug CandidatesChemBioChem, 2019
- Palladacyclopentadienyl complexes bearing purine‐based N‐heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancerApplied Organometallic Chemistry, 2019
- Cyclometalated Palladium(II) N‐Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth SuppressionAngewandte Chemie International Edition, 2016
- Mechanisms of ferroptosisCellular and Molecular Life Sciences, 2016
- Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studiesMedicinal Research Reviews, 2009
- In vitro cell growth inhibition by metallocene dichloridesCancer Chemotherapy and Pharmacology, 1981